American Financial Statements From 2010 to 2024

ERBB Stock  USD 0.0006  0.0001  20.00%   
American Green financial statements provide useful quarterly and yearly information to potential American Green investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on American Green financial statements helps investors assess American Green's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting American Green's valuation are summarized below:
American Green does not presently have any fundamental signals for analysis.
Check American Green financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among American Green's main balance sheet or income statement drivers, such as , as well as many indicators such as . American financial statements analysis is a perfect complement when working with American Green Valuation or Volatility modules.
  
This module can also supplement various American Green Technical models . Check out the analysis of American Green Correlation against competitors.

American Green Company Price To Sales Analysis

American Green's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

 = 

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current American Green Price To Sales

    
  736.84 X  
Most of American Green's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, American Green is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Based on the latest financial disclosure, American Green has a Price To Sales of 736 times. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to sales for all United States stocks is notably lower than that of the firm.

American Green Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining American Green's current stock value. Our valuation model uses many indicators to compare American Green value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across American Green competition to find correlations between indicators driving American Green's intrinsic value. More Info.
American Green is one of the top stocks in operating margin category among its peers. It is rated # 4 in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value American Green by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for American Green's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About American Green Financial Statements

American Green stakeholders use historical fundamental indicators, such as American Green's revenue or net income, to determine how well the company is positioned to perform in the future. Although American Green investors may analyze each financial statement separately, they are all interrelated. For example, changes in American Green's assets and liabilities are reflected in the revenues and expenses on American Green's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in American Green. Please read more on our technical analysis and fundamental analysis pages.
American Green, Inc. operates as a technology company in the medical cannabis industry in the United States. The company was formerly known as Tranzbyte Corporation and changed its name to American Green, Inc. in May 2014. American Green is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in American Pink Sheet

American Green financial ratios help investors to determine whether American Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in American with respect to the benefits of owning American Green security.